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Experimental research in humans and animals points to the importance ofadverse respiratory
effects from short-term particle exposures and to the importance ofproinflammatory effects of
airpollutants, pcularly 03. However, partide averagingtimehas notbeensubjected to direct
scientific evaluation, and there is a lack ofepidemiological research examining both this issue
andwhether modification ofairpollutant effcs occurs with differences in asthma severityand
anti-inflammatorymedication use. The present studyexmined the relationship ofadverseasth-
ma syptoms (bothersome or interfered with daily activities or sleep) to 03 and partides <10
Pm (PM10) in a Southern Califoria community in the air inversion zone (1200-2100 fi) with
high 03 and low PM (R = 0.3). A panel of25 asthmatics 9-17 years ofagewere followeddaily,
August through October 1995 (n - 1,759 person-days exduding one subject without symp-
toms). Exposures inldudedstationaryoutdoorhourlyPM0 (highest 24-hr mean, 54plWm3, ver-
sus median of 1-hr maximums, 56 pg/m3) and 03 (mean of 1-hr maximums, 90 ppb, 5 days
>120 ppb). Longitudinal regression analyses utlized thegenerized estimatingequations (GEE)
model controlling for autocorrelation, day ofweek, outdoor fingi, and weather. Asthma symp-
toms were significantly associated with both outdoor 03 andPM10 in single pollutant- and co-
regressions, with 1-hr and 8-hr maximum PM10 having larger effects than the 24-hr mean.
Subgroup analyses showed effects ofcurrent dayPM1O maximums were strongest in 10 more
frequently symptomatic (MS) children: the odds ratios (ORs) for adverse symptoms from 90th
percentile increases were 2.24 [95% confidence interal (CI), 1.46-3.461 for 1-hr PM10 (47
pg/in3); 1.82 (CI, 1.18-2.81) for 8-hr PM10 (36 pg/m3); and 1.50 (CI, 0.80-2.80) for 24-hr
PM1O (25 pg/m3). Subgroup analyses also showed the effc ofcurrent day03 was strongest in
14 less frequendty symptomatic (LS) children: the ORs were 2.15 (CI, 1.044.44) for 1-hr 03
(58 ppb) and 1.92 (CI, 0.97-3.80) for 8-hr 03 (46 ppb). Effects of24-hrPM1O were seen in
both groups, particularlywith 5-day moving averages (ORs were 1.95 for MS and 4.03 for IS;
pr0.05). Thelargesteffects were in 7 ISchildren not onanti-inflammatorymedications [5-day,
8-hr PM1O, 9.66 (CI, 2.80-33.21); current day, 1-hr 03, 4.14 (CI, 1.71-11.85)]. Results sug-
gestthat examination ofshort-term partide excursions, medication use,and symptomseverityin
longitudinal studies ofasthmayields sensitive measures ofadverse respiratoryeffects ofairpollu-
tion. Key work asthma, epidemiology, longitudinal data analysis, ozone, panel study, particu-
late airpollution. EnvironHealthPerspet106:751-761 (1998). [Online 22 October 1998]
http:llehpnetl.niebs.nib.gvv/docs/)998/106p751-76ldefino/abstract.tml
Recent experimental findings in humans
indicate adverse respiratory effects from
short-term exposures to particulate air pollu-
tants delivered over 1 to several hours (1).
Therefore, it is biologically plausible that
short-term excursions ofparticulate airpollu-
tion in communities could have adverse
impacts on the respiratory health ofsuscepti-
ble individuals. However, in theexperimental
work to date, averaging time has not been
subjected to direct scientific evaluation. For
example, it is not known whether, for any
given partide type, agreater orlessereffect on
respiratory outcomes would occur forequiva-
lent delivered doses given over shorter times
(1 to several hours) as compared with longer
times such as 24 hr (current EPA averaging
timeforregulatory monitoring). Also, there is
a lack ofepidemiological research examining
respiratory effects from peak partide expo-
sures since mosthave relied on daylong aver-
aging times, namely 24-hr means or occa-
sionally 12-hr diurnal means. It has been
suggested that the epidemiologic findings
showing adverse effects ofparticulate matter
<10 pm (PM1O) levels below the current
U.S. National Ambient Air Quality
Standards (NAAQS) could be partly
explained byunmeasured short-term particle
excursions that are captured somewhat by
24-hr averages (4. In fact, prior to recent
EPA regulatory proposals for tightening the
NAAQS for PM and 03, the EPA's Clean
Air ScienceAdvisory Committee advised the
EPA to give a scientific rationale for the 24-
hrPM1O averaging time in the NAAQS (3).
To our knowledge, there are no epidemio-
logic studies reported in the peer-reviewed
literature that have analyzed respiratory
effects ofpeakpartideconcentrations.
The current controversy over the EPA's
regulatory changes center on the argument
that improved standards are needed to pro-
tect the most susceptible subgroups in the
U.S. population such as asthmatics. A recent
review of the epidemiologic literature on
PM and asthma suggests that mean levels of
PM in North America and Europe, often
within the previous NAAQS, may be
responsible for increases of2-5% in asthma
hospital admissions and 5-10% in asthma
emergency room (ER) visits (4). Supporting
experimental data for asthma exacerbations
from PM are largely indirect, but suggest
that partide deposition in the lower respira-
tory tract can cause inflammation, dimin-
ished mucociliary clearance and macrophage
function, and adverse changes in lung func-
tion (5). The role of03 in airway inflamma-
tion is more clearly supported by experi-
mental evidence showinggreater increases in
03-induced inflammatory markers in bron-
choalveolar lavage (BAL) fluid in asthmatics
than in normal subjects (6). Such an effect
has been hypothesized to enhance allergen-
induced bronchoconstriction in asthmatics
(7). Clearly, there is a scientific need for
explanations of epidemiologic findings of
adverse effects on asthmatics by both PM
and03 at lowambient concentrations.
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Because asthmatics differ greatly with
respect to disease severity, which is to a
large extent dependent on the magnitude
of underlying pulmonary inflammation,
the proinflammatory effects of air pollu-
tants will likely vary in more versus less
severe asthmatics. Air pollutant effects may
also differ depending on whether an asth-
matic is taking anti-inflammatory medica-
tions, including inhaled corticosteroids,
which are now considered to be the most
effective front-line therapy for recurrent
chronic asthma (8). Therefore, reported
effects of pollutants on asthmatic popula-
tions in epidemiologic studies may under-
estimate effect magnitudes in particularly
susceptible subgroups.
The objective ofthisstudy is to examine
the relationships ofdaily asthma severity to
1-hr maximum and 8-hr maximum PMIO
and 03, and 24-hr mean PMIo among 24
nonsmoking pediatric asthmatics living in
nonsmoking households. Outdoor concen-
trations ofPM1O were measured with a
tapered-element oscillating microbalance
(TEOM; Rupprecht and Patashnick, Inc.,
Albany, NY), an inertial instrument that
measures particle mass in real time (9). The
strength of association will be compared
between 1) the different averaging times; 2)
subjects having varying magnitudes ofasth-
ma symptom severityduring follow-up; and
3) asthmatics taking and not taking anti-
inflammatory medications. Comparisons 2
and 3 aim to identify potentially susceptible
subgroups ofasthmatics.
Materials and Methods
Research design. The present investigation is
a panel study, a longitudinal study charac-
terized by repeated measurements ofhealth
outcomes and exposures in individuals.
Whittemore and Korn (10) originallyadapt-
ed the panel study for a study that showed
acute adverse associations of03 and particu-
late air pollution with asthma attacks in a
Los Angeles, California, cohort followed in
the 1970s. The present study examines the
relationship ofdaily diary reports ofasthma
symptom severity to airborne environmental
risk factors measured at a central outdoor
site in Alpine, California, from 1 August to
30 October 1995.
The panel design makes it possible to
determine the temporality of associations
(i.e., the putative cause precedes the out-
come) and to observe individual patterns of
change in exposure and response (11).
These advantages areparticularly well suited
to the study ofillnesses such as asthmawith
acute-on-chronic patterns ofchange. Other
major advantages of the panel design are
that the use ofdaily diaries reduces the like-
lihood ofrecall bias, given the proximity of
events, and that health effects can be mod-
eled with each subject serving as his or her
own control over time. The last advantage
in design shares similar features to the
crossover clinical trial in that both study
designs are statistically efficient (enhanced
signal-to-noise ratio) because multiple
treatment or exposure conditions are stud-
ied in each subject and variability in expo-
sure-response relationships due to
between-subject characteristics is controlled
for by design (12). The last advantage is
due to a reduction in the variability ofthe
response variable without reductions in the
magnitude of the exposure-response rela-
tionship, thereby enhancing power and
precision (11). These advantages are largely
lost when individual responses on each day
of observation are aggregated into time
series with variable numbers ofparticipants
from day to day.
Studypopulation. The region studied is
a semirural area of Southern California
around the small town ofAlpine, an inland
community ofapproximately 12,000 people
living within the air inversion mixing zone
(town at elevation of 1800 ft, range
1200-2100 ft). This zone typically has high
03 concentrations due to transport ofurban
air masses from San Diego and Los Angeles,
with photochemical oxidation of nitrogen
oxides and hydrocarbons. The community
was originally targeted for research to maxi-
mize the ability to isolate the independent
effect of03 from that ofparticulate air pol-
lutants. In other air pollution studies of
urban areas, this task has been difficult due
to high pollutant covariation. This separa-
tion was possible with Alpine data because
ofhigh 03 and lowPM10 concentrations, as
well as weak correlations between the two
pollutants (between-pollutant R <0.32 for
various averagingtimes).
The institutional review board of San
Diego State University approved the study
protocols. Informed written consent was
obtained from all children and adolescents
and one oftheirlegalguardians. Recruitment
ofsubjects was done with newspaper adver-
tisements, with the assistance of the Alpine
School District nurse covering all four grade
schools and with referrals from the Kaiser
Permanente Health Plan, Inc., San Diego
Area, Department ofAllergy. Monetary
incentives were an essential component of
both recruitment and maintenance ofcom-
pliance during follow-up. Subjects were not
told what specific exposures were being
monitored, but were simply told that the
study involved the examination of environ-
mental agents indudingoutdoorallergens.
Eligibility criteria included 1) physician-
diagnosed asthma with a minimum history
of 1 year; 2) asthma exacerbations during
several weeks of the warm seasons (March
through October) requiring the use of pre-
scribed asthmamedications; 3) ages between
9 and 18 years; and 4) a home and school
address in Alpine or adjacent areas. Also,
smokers and subjects exposed to environ-
mental tobacco smoke at home wereexclud-
ed to reduce the influence ofthis risk factor.
Eligibility criterion number 2 was intended
to target subjects having frequent episodes
of asthma symptoms requiring medication
and adversely impacting the subject's daily
life. This enhances the representation of
asthma populations with a more frequent
incidence ofdinically severe outcomes that
have been associated with air pollution ele-
vations (e.g., asthma hospital admissions).
Asthmamortalityalso occurs predominandy
among this group (8). Very mild asthmatics
with infrequent exacerbations, particularly
youngchildren, are morelikely to have their
asthma exacerbations with respiratory infec-
tions (13). Therefore, the targeted popula-
tion has particular relevance to the public
health impact ofairpollutants.
Twenty-five asthmatics 9-17 years ofage
agreed to participate and were interviewed
and trained. One 14-year-old girl dropped
out at 69 out of91 days, but her data were
retained for analysis. Since subjects were
recruited into the third week ofSeptember,
the minimum to maximum potential per-
son-days ofobservation was42-91.
Asthma symptom score. In the evening,
subjects recorded the level ofasthma symp-
tom severity for the previous 24 hr.
Subjects were followed-up weekly during
the first 2-3 weeks, then biweekly at their
home forvalidity checks to insure the accu-
racy of diaries and compliance with the
study protocol. Also, questions by partici-
pants wereregularlyanswered face to face.
Daily diary questions concerning asth-
ma symptoms emphasize the impact ofthe
clinical severity of asthma on the normal
daily activities that are typical for each indi-
vidual. Subjects received training in inter-
preting the scoring system in this manner.
Because the complex of symptoms recog-
nized or experienced by asthmatics differs
from one person to another, the approach
used combines the rating ofvarious symp-
toms into one score that relates, in part, to
the impact of asthma on a subject's daily
well-being. Asthma symptoms (cough,
wheeze, sputum production, shortness of
breath, and chest tightness) were rated by
the subjects in terms of their combined
severity on a scale from 0 to 5. This classifi-
cation contrasts a commonly used approach
ofdichotomizing each individual symptom
into present or absent. The clinical severity
of asthma in many asthmatics could be
obscuredby asymptom-specific approach.
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Subjects classified the six levels ofasth-
ma severity as 0, no asthma symptoms pre-
sent; 1, asthma symptoms present but
caused no discomfort; 2, asthma symptoms
caused discomfort but did not interfere
with daily activities or sleep; 3, asthma
symptoms interfered somewhat with daily
activities or sleep; 4, asthma symptoms
interfered with most activities and may
have required that the participants stay
home in bed, return home early from
school, or call a doctor or nurse for advice;
5, asthma symptoms required going to a
hospital, ER, or outpatient clinic.
The asthma symptom score was used to
create the response variable representing the
occurrence of asthma symptoms that have
an adverse impact on the subject's well-
being. This is a dichotomous variable
derived as follows: no asthma symptoms or
symptoms not bothersome (score 0 or 1)
versus symptoms that are bothersome or
interfere with dailyactivities (score >1). This
cut point was chosen for the following rea-
sons. First, a cut point between 0 and 1 was
not used because symptoms not considered
by the subject to be bothersome have agood
chance ofnot being dinically meaningful in
the absence ofcontemporaneous lung func-
tion measurements indicating an acute
deficit. Second, only 10% of the symptom
observations were >2; ofthese observations,
only 17 person-days had a score of4, and
only 3 person-days had a score of 5.
Separate analysis of these more clinically
severe outcomes was not informative, possi-
bly due to limited statistical power. In one
mildly symptomatic subject, all binary val-
ues were 0. Consequendy, the data analysis
excludes this subject. The remaining 24 par-
ticipants contributed 1,759 person-days of
symptom observations for the analysis out of
apotential of1,895 person-days.
Environmental variables. Continuous
monitoring of outdoor 03 was conducted
using UV photometry at a stationary out-
door monitoring station located centrally in
Alpine and operated by the San Diego Air
Pollution Control District. The PMIO con-
centrations were recorded with a TEOM in
real-time (9) located at the same site. The
PMIO data were used as 1-hr averaged data,
similar to standard 03 monitoring, but in
contrast to the standard 24-hr filter-pack
PM1O. The TEOM is certified by the EPA
for measuringPM1O concentration. It incor-
porates an inertial balance that measures the
mass on an exchangeable filter cartridge by
monitoring frequency changes of a tapered
element. The TEOM sampler inlet was
operated at 16.7 1/min and the inlet air
stream was heated to a constant 50°C to
keep water in the vapor phase. We did not
collect samples fordailypartide composition
orsize fractions. Sampling, analysis, and data
processing protocols for PM1O were carried
out as part ofanother ongoing project at the
University of Southern California (14).
Twentycontiguous days from 10-29August
were missing because ofTEOM equipment
malfunction. Hourly temperature, relative
humidity, and wind speed were also mea-
sured atthe stationaryoutdoorsite.
There were low concentrations of out-
door pollen during the dry part ofthe year
(August-October) in this semiarid desert
region (mean, 55 pollen grains/m3).
Therefore, bioaerosol analyses focus on
fungi, many ofwhich thrive on the decay-
ing biomass of the region's chaparral.
Measurements of fungal spores were made
at the stationary outdoor site using the
Burkard 7-day recording volumetric spore
collector with a sample flow rate of 10
1/min (Burkard Manufacturing Co. Ltd.,
Rickmansworth, Hertfordshire, England).
The methods of sample collection and
quantification have been previously
described (15). Fungal spores and hyphal
fragments were microscopically counted
and identified by 12-hr segments from 900
to 2100 hr and from 2100 to 900 hr. The
fungal counts were then converted into
particles per cubic meter ofair for each 12-
hr and 24-hr (2100-2100 hr) time period
(approximate diary reporting period).
Statistical analysis The analysis began
with descriptive statistics, which included
time plots for the examination of possible
trends in the data. Exposure correlation
matrices were constructed to assess the
amount ofintercorrelation, which could pre-
dict potential confounding or collinearity
effects in the regression analyses. The regres-
sion analysis ofpollutant effects on the bina-
ry symptom score utilized generalized esti-
mating equations (GEE). The GEE
approach was developed by Liang and Zeger
(16) for nonnormal response data that are
discrete and correlated (within-individual
clusters). Repeated daily measurements over
time in individuals constitute a cluster of
observations. The model is conceptually aset
of separate regression models on repeated
measurements in each individual. Therefore,
every subject can act as his or her own con-
trol. The GEE models were tested using the
logitlink in the SAS generalized linearmodel
procedure GENMOD (SAS Institute, Cary,
NC). The GENMOD procedure uses a
ridge-stabilized Newton-Raphson algorithm
to maximize the log likelihood function for
the regression parameters.
The GEE approach used is well-suited to
panel data because it can be applied to
repeated measures that are unbalanced, have
unequal numbers ofobservations in different
individuals, or have missing observations;
and it accounts for temporally correlated
responses and the dependence ofrepeated
observations in single individuals. Serial cor-
relation was accounted for with ARI para-
meters to control autocorrelation ofresidual
errors, apotential sourceofbias.
Analyses were also performed on various
subgroups as an approach to identifying
potentially susceptible populations ofasth-
matics. These groups were 1) less versus
more frequently symptomatic asthmatics
and 2) asthmatics taking versus not taking
regularlyscheduled anti-inflammatory med-
ications. For the first case, the panel was
split into two groups: onewith lessfrequent
symptoms (LS), defined as <20% ofdays
with asthma symptoms that were bother-
some or interfered with daily activities, and
another with more frequent symptoms
(MS), defined as .20% ofdays with such
symptoms. These two groups were defined
as such because the subjects fell into two
relatively distinct groups from examination
of frequency distributions of the ordinal
symptom scores in each subject. When the
average symptom scores for each day of
study were compared between the two
groups, two minimally overlapping normal
distributions were observed. Also, using 0/1
as a cut point on the ordinal symptom
scale, the LS group is close to the National
Heart Lung and Blood Institute (NHLBI)
criteria for defining asthma severity as mild
intermittent (symptoms <2 times/week),
and the MS group is dose to the NHLBI
criteria for mild persistent or worse severity
(symptoms >2 times/week) (8). There were
no severely asthmatic subjects with constant
symptoms, such as those requiring long-
term oral steroids.
Delayed air pollutant effects were
examined by regressing symptoms on pol-
lution levels measured on up to 6 days
before the day of symptom reporting.
Moving averages combining air pollution
levels on current and lag days were also
tested after examining the distribution of
individual daylag effects (17). Because pol-
lutants were measured on 6 days before the
start ofthe study, it was possible to test lag
effects from the first day of follow-up.
However, lags and moving averages for
PM1O were missing for up to 5 days follow-
ing the time the TEOM was malfunction-
ing. Several lag days forPMIO were signifi-
cant in the regression models, induding 1
and 4 days before the day of symptom
reports. The largest and most robust effects
were found for 5-day moving averages of 1-
hr, 8-hr, and 24-hr PM o. Therefore,
results focus on effects of current day and
5-daymoving averages ofPM1O.
We previously showed that outdoor fun-
gal aerosols have adverse effects on asthma
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Table 1. Descriptive statistics forasthmatic subjects, August-October 1995 in Alpine, California
Mean age No. males/
Mean daily
symptom score
No.subjects on
anti-inflammatory
Meandaily
as-needed
5-agonist
inhaler
Group (range) females ± SD medications (%) puffs ± SD
MSa 13.1 (9-16) 7/3 1.40 ± 1.18 1 1.21 ± 1.58
LSb 12.7(10-17) 8/6 0.40± 0.75 7 1.03 ±3.33
LS asthmatics on
anti-inflammatory medications 11.4(10-16) 5/2 0.47 ± 0.81 7 2.36 ± 4.91
LS asthmatics noton
anti-inflammatory medications 14.0(11-17) 3/4 0.33 ± 0.68 0 0.14 ±0.53
Overall (n=24) 12.9(9-17) 15/9 0.80± 1.07 8(33) 1.11 ±2.72
Abbreviations: MS, more symptomatic; LS, less symptomatic; SD, standard deviation.
8MS asthmaticsweredefined ashaving 2(0% ofdayswith asthma symptomsthatwere bothersome orinterfered withdailyactivities(10asthmatics).
bLS asthmatics were defined as having <20% ofdays with asthma symptoms that were bothersome or interfered with daily activities during
follow-up (14asthmatics).
Table2. Descriptive statistics for daily air pollution and weather measurements, 1 August-30 October 1995 in
Alpine, California
Exposure and averaging time No. obs Mean± SD Min/max 90th Percentile
03 outdoor 1-hr max(ppb)8 91 90 ± 18 52/135 110
03outdoor 8-hr max(ppb) 91 73 ± 15 44/110 90
PM10 1-hr max(pg/m3)b 71 57 ± 16 30/108 77
PM108-hr max(pg/m3) 71 43 ± 12 23/73 59
PM10 24-hr mean (pg/m3) 71 31 ± 8 16/54 42
Fungi 12-hr daytime mean (particles/m3) 91 3,043 ± 1,818 844/15,594 4,510
Fungi 24-hr mean(particles/i3) 91 2,676 ± 1,263 1,191/9,094 3,812
Temperature 1-hr max(OF) 91 88 ± 8 72V103 98
Relative humidity 24-hour mean (%) 91 48 ± 19 16/89 82
Wind speed 12-hr mean (mph)c 91 4.1 ± 0.6 2.7/5.3 4.8
Abbreviations: obs, observations; SD, standard deviation; min, minimum; max, maximum; mph, miles per hour.
'The stationary site outdoor monitor wasthe Alpine site operated bythe San Diego Air Pollution Control District.
t1wenty days are missing because oftapered-element oscillating microbalance equipment malfunction.
cLevelsforthe 12-hrsampling period were averaged from 800to 2000 hr.
symptoms in previous panel studies in San
Diego and Alpine (15,18,19). However, the
present analysis focuses on airpollutants, and
total fungal partides will be used as a control
variable for air pollutant effects following an
examination offungi-pollutant interactions.
Our previous analyses of asthma and out-
door fungi have been extensive, involving
numerous fungal types, and stratified by the
allergic sensitization of subjects (15).
Therefore, we will present such detailed
analyses on this cohort in alater report.
A local brush fire occurred during the
last 3 days when the TEOM sampler was
malfunctioning (27-29 August). Regression
analysis including an indicator variable for
this event showed no association with asth-
ma symptoms and no confounding of 03
models. Possible reasons for no associations
include the limited statistical power ofmod-
eling this relatively brief event and reports
from subjects and their parents that outdoor
activity was restricted by choice, which may
have diminished smoke exposure. Models
were also tested for confounding by day of
week trends, temperature, relative humidity,
andwindspeed. Confoundingwas indicated
by at least a 15% change in the parameter
estimate for the pollutant. The analysis of
wind speed was intended to examine the
possible importance ofwind-blown dust to
particle effects. Deviance statistics for GEE
models were used to assess the fit ofvarious
models. Comparisons ofthe fit ofsingle ver-
sus co-pollutant models for03 were initially
restricted to dayswith nonmissingPMIO.
Results
Subject characteristics. Most subjects were
white, non-Hispanic except for four
Hispanics, one African American, and one
Asian. This distribution reflects theracial/eth-
nicmake-up oftheAlpinecommunity. Table
1 shows the characteristics of the asthmatic
subjects by the groups analyzed. Eight sub-
jects were using daily inhaled anti-inflamma-
tory medications (six subjects were on corti-
costeroids, one on cromolyn and one on
nedocromil). Only one pediatric MS asth-
matic was on an anti-inflammatory medica-
tion (nedocromil), leaving insufficient power
to make a comparison ofanti-inflammatory
users versus nonusers. Seven asthmatics on
anti-inflammatory medications were LS asth-
matics, suggesting that some ofthe LS asth-
matics hadless frequentsymptoms because of
their treatment regimen. The medicated LS
subjects had a similar average symptom score
but used more as-needed ,-agonists andwere
younger. The one LS subject with all binary
symptom values = 0 was a 14-year-old white
male taking virtually no medication during
the study (not shown in Table 1). Other
characteristics indude a 2:1 ratio ofmales to
females, which reflects the typical pediatric
asthma distribution. The ratio was higher in
MS asthmatics and in LS asthmatics on anti-
inflammatorymedications.
Exposures. Exposures are described in
Table 2. These concentrations of O31
PM1O, and fungi are typical for the warm
seasons in Alpine and are similar to our
previous Alpine panel studies (15,19).
During this warm and dry period, only 5
of 91 days had 03 levels over 120 ppb
(previous NAAQS). The hourly PM1O data
showed very different concentration pro-
files depending on the averaging time
(Table 2). For instance, the highest 24-hr
mean PM measurement was 54 pg/m3 as
compared with the median of 1-hr maxi-
mum PM10 of 56 pg/m3. Figure 1 also
shows this difference over time. The high-
est PM1O hourly exposures were from 900
to 1900 hr (>68 pg/m3) with the highest
hourly peaks largely occurring between
1300 and 1600 hr (80-108 pg/m3). A sim-
ilar distribution for peak hours of0 con-
centrations was found. Outdoor fungal
particle concentrations were moderate,
with higher levels during the daytime.
Table 3 shows the correlation between
the different exposures. The correlation
between PM10 and 03 was low (<0.32 for
various averagtng times), in contrast to
warm periods in most urban areas. This
prevented major problems of multi-
collinearity in linear regression. Another
departure from patterns commonly report-
ed for urban aerosols is the lack ofcorrela-
tion of PM1O to temperature or relative
humidity. As expected for Southern
California, 03 is often higher on hotter
and dryer days. Daytime average wind
speed was weakly and inversely correlated
with PM1O, suggesting that wind-blown
dust and its associated coarse particle frac-
tion (PM2.5-10) was not a major contribu-
tor to PM1O mass. Maximum hourly wind
speed and 24-hr mean wind speed were
more weakly, but still inversely, correlated
with PM1O variables (not shown). It is like-
ly that cool offshore winds from the Pacific
Ocean (indicated by wind direction) led to
cleaner air masses.
Regression analysis. For the GEE analy-
sis, the magnitude of effect is expressed as
the odds of asthma symptoms for a 90th
percentile increase in the pollutant from its
minimum level. In the analysis of the
whole group of 24 subjects, asthma symp-
toms were significantly associated with
both PM1O and 03 (Table 4). The GEE
models adjusted for confounding day of
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Figure 1. Time plot of dailytapered-element oscillating microbalance (TEOM) PM10 in the Alpine Asthma Panel Study, Augustto October 1995: comparison of max-
imum hourly with 24-hr average PM10 ______
Table 3. Air pollution and weather correlation matrix8 1 August-30 October 1995 in Alpine, California
week trends due to both higher average
symptoms and PM1O on weekdays than on
weekends. Models also adjusted for maxi-
mum temperature, which was inversely
associated with symptoms [, = -0.021,
standard error (SE) = 0.013], consistent
with our previous investigation in Alpine
(15). There was no confounding ofPM1O
or 0 effects by minimum or average rela-
tive humidity, which were not associated
with symptoms. Symptoms were not signif-
icantly associated with wind speed using
any averaging time, and wind did not con-
found PM1O or 0 effects. Parameter esti-
mates were actua?ly negative for asthma
symptoms andwindspeed.
Table 4 shows that relative pollutant
effect sizes for particles measured on the
same day as symptom reports were 1-hr
PMIO - 8-hrPM1O >24-hrPM1O. The odds
ratio (OR) for current day 24-hr PM1O was
nonsignificant in contrast to highly signifi-
cant effects for 1-hr and 8-hr PM10 averag-
ing times (p<0.005). Co-regression of 03
withPM0o did notnotablychange the effect
magnitudes or relative differences in averag-
ing time for PM1O Parameter estimates for
5-day moving averages of 1-hr, 8-hr, and
24-hrPM1O were larger than the current day
PM1O (Table 4). These associations were
8-hrmax 1-hrmax
03 PM10
8-hrmax
PM10
12-hr
24-hr daytime
mean PM10 fungi
24-l
mei
funi
1-hrmax03 0.90' 0.26* 0.31** 0.31** 0.07 0.1
8-hrmax03 0.20 0.26* 0.32** 0.07 0.1
1-hrmaxPM10 0.88' 0.76' 0.24* 0.2
8-hrmaxPM10 0.89' 0.19 0.1
24-hrPM10 0.19 0.
12-hrfungi 0.'
24-hrfungi
Maxtemperature
24-hrrelative humidity
Max, maximum. apearson correlation coefficients (p-value) for91 ozone observations and 71 PM10observations.
*p<0.05;**p<0.01;8p<4.W1.
onlysignificant for 8-hr and 24-hr averaging
times. The largest effect was for 5-day 8-hr
maximum PM1O [OR = 2.25; 95% confi-
dence interval (CI), 1.24-4.07]. These
effects were virtually unchanged when co-
regressingwith 03.
There were also significant effects of
both current day 1-hr and 8-hr 03, with
little difference in the magnitude of risk.
Co-regression with current day 1-hr maxi-
mum PM1O showed similar 03 effect sizes,
but confildence limits were below 1.
However, co-pollutant models exclude 20
days with missingPM1O and are not strictly
comparable to single pollutant 03 models.
*hr
!an
1gi
16
16
20
17
22
901
12-hr
24-hrmean daytime
Maximum relative wind
temperature humidity speed
0.54' -0.31** 0.07
0.57' -0.41' 0.13
0.10 -0.05 -0.14
0.07 -0.03 -0.24*
0.10 0.02 -0.17
-0.03 0.10 -0.11
0.02 0.02 -0.10
-0.70' 0.57'
-0.42'
The comparison to a model with 03 alone,
restricted to 71 days with nonmissing
PMIO data, showed that ORs for 03 were
similar to models for all 91 days (OR =
1.57; CI, 1.01-2.44). There was little dif-
ference in 03 concentrations between these
71 days (mean 90, range 52-135 ppb) and
the 20 days with missingPM1O data (mean
90, range 68-110 ppb). This suggests that
effects of 03 and PM1O were largely inde-
pendent and the increased standard error
for the effect of03 was due to minor vari-
ance inflation byPM1O.
The robustness ofthe above models was
retested accounting for fungal particles. For
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Table 4. Odds ratios (ORs) for asthma symptoms" among 24 pediatric asthmatics in relation to 90th per-
centile increases in PM10 and 03 concentrations: dependence on pollutant averaging times in the Alpine,
California, Panel Study, 1 August-30 October 1995
ORs (Cl) per
increase to 90th percentile
concentration ofPM10 or 03
Air pollutant range (minimum Models adjusting for
Air pollutantvariable to 90th percentile)b Single pollutant modelsc co-pollutantd
CurrentdayPM10
1-hr max 47 1.72 (1.23-2.39)# 1.63 (1.17-2.28)#
8-hr max 36 1.73 (1.22-2.46p 1.59(1.13-2.23)**
24-hr mean 25 1.47 (0.90-2.39) 1.31 (0.84-2.06)
5-Day moving average PM10
1-hr max 47 1.82(0.94-3.47) 1.80(0.96-3.35)
8-hr max 36 2.25(1.24-4.07)** 2.15(1.24-3.75)**
24-hr mean PM10 25 1.73 (1.03-2.89)* 1.65(1.03-2.66)*
Current day 03
1-hr max 58 ppb 1.54(1.02-2.33)* 1.46(0.93-2.29)
8-hr max 46 ppb 1.42(1.00-2.00)* 1.31 (0.88-1.96)
Abbreviations: Cl, 95% confidence interval; max, maximum.
'The asthma symptom severity score was dichotomized to no symptoms or symptoms not bothersome versus symptoms bothersome or inter-
fering with daily activities.
bValues shown are pg/iM3 exceptwhere indicated.
CSingle pollutant models involve 71 days for PM10 and 91 days for 03 models; models adjust for day-of-week trends and maximum tempera-
ture {lag 0 models).
dAll PM10 co-pollutant models adjust for current day 1-hr max 03; 03 co-pollutant models adjust for current day 1-hr maximum PM,0. All co-
pollutant models are for71 dayswith nonmissing PM10data;therefore, single pollutant 03 models are notstrictly comparable.
*p<0.05;**p<4.01;'p<0.001.
an increase from the minimum to 90th per-
centile of fungi (see Table 2), the OR for
the prior 24-hr average fungi was 1.36 (CI,
1.11-1.67), and the OR for the prior 12-hr
daytime fungi was 1.25 (CI, 1.07-1.45),
controlling for day-of-week trends. Fungal
particles did not confound effects ofany of
the expressions ofeitherPM1O or 03.
There was a significant linear time trend
over the study period of increasing 8-hr
maximum PM1O and decreasing 1-hr and 8-
hr 03 (p<0.05), but not other expressions of
PM10 (p<0.4) or symptoms (p<0.2). When
an ordinal variable representing day ofstudy
was added to the GEE models, there was no
confounding ofpollutant effects.
Regression diagnostics using deviance
residuals did not reveal any particular per-
son-day observations to be overly influential
to model parameters. To assess the influ-
ence of individual asthmatics on model
parameters, each subject was dropped from
the analysis and models were rerun with the
remaining 23 of 24 subjects. There were
some minor decreases in 03 parameter esti-
mates for 7 subjects, none of whom were
taking inhaled corticosteroids. Three were
LS asthmatics (one on cromolyn), and 4
were MS asthmatics (one on nedocromil).
The 23-subject ORs ranged from 1.44 to
1.48 (p<0.07 top<O.1, respectively) as com-
pared with an OR of 1.54 (p<0.05) in the
model with all 24 subjects. These subgroup
effects are further analyzed below.
The effects ofpollutants were re-tested
after splitting the panel into two groups
based on their symptom frequency during
follow-up (LS vs. MS). Table 5 shows mod-
els for the relationship of symptoms to air
pollutants in each group and reveals infor-
mative differences in exposure-response rela-
tionships otherwise obscuredwhen analyzing
the group as awhole. Findings forsingle pol-
lutant models in Table 5 are as follows.
There were no significant effects of current
day 1-hr maximumPM1o in the LS asthmat-
ics, whereas the 24-hr averagePM1O was sig-
nificant and the 8-hr maximum was ofbor-
derline significance. Relative effects ofvari-
ous averaging times for current dayPM1O in
LS asthmatics were the inverse ofresults for
the combined cohort: 24-hr PMIO >8-hr
PM1O >1-hr PM1O. The analysis of lagged
day PM10 effects in LS asthmatics revealed
significant associations between symptoms
and 5-daymovingaverages of1-hr, 8-hr, and
24-hr PM1O, with ORs higher than those of
any single day, including current day PM1O
(Table 5). These relationships were only sig-
nificant for 8-hr and 24-hr averaging times,
reflecting results for all subjects. Again, the
largest OR was for 5-day 8-hr maximum
PM1O (OR = 4.84; CI, 1.21-13.33), nearly
double that of the 5-day 1-hr PM10, but
only somewhat higher than the 5-day 24-hr
PMO1 Significant effects for current day 03
were found only in LS asthmatics (p<0.05).
Therewere nolagdayeffects of03.
In contrast to LS asthmatic children, but
reflectingregression results for thecombined
cohort, significant effects for current day 1-
hr maximumPM1O were found in MS asth-
matic children (p<0.0002). Effects of03 on
this group were small and not significant.
Relative partide effect sizes in MS asthmat-
ics were current day 1-hrPM1O >8-hrPM1O
>24-hr PM1O. The analysis ofMS asthmat-
ics also revealed significant effects ofPM1O
5-day moving averages (Table 5). In con-
trast to LS asthmatics, nearly equivalent
effects are seen for 5-day averages ofvarious
averaging times (ORs around 2). For 8-hr
and 24-hr PM1O, these ORs were around
halfthose found in LS asthmatics.
The single pollutant models usually pro-
vided the best fit (no change in deviance sta-
tistics adding the co-pollutant). The excep-
tion was for LS asthmatics, in which the
models for current day PM1O were best fit
with 1-hr maximum 03 (deviance difference
>4.0). Co-pollutant models are presented in
the last column ofTable 5. In LS asthmatics,
the effect ofcurrent day 24-hr PMIO when
regressed with 1-hr maximum 03 was still
p<0.02 (OR = 2.08) and the relative differ-
ences in effects between averaging times were
preserved. Similarly, in co-regression models
controlling for current day 1-hr 03, the 5-
daymoving averages for both 24-hr and 8-hr
PMIOstill hadmoderatelystrongeffects (ORs
= 3.4 and 4.0, respectively) and were signifi-
cant. In contrast to the single pollutant 03
model, when currentday03was co-regressed
with current day 24-hr PM1O in LS asthmat-
ics, the lower confidence limit for 03 was
well below 1.0. Models with 03 alone
restricted to 71 days with nonmissing PM
showed that ORs were similar to models for
all 91 days, but confidence limits were also
wellbelow 1.0 (p<O.15) as in theco-pollutant
model [1-hr 03 OR = 2.14 (CI, 0.79-5.76);
8-hr 03 OR = 1.88 (CI, 0.79-4.52)]. Co-
regression ofcurrent day 24-hr PM and 1-
hr 03 led to similar reductions in each of
their regression parameters (16% for PM1O
versus 18% for 03, or 2.47 to 2.08 , versus
2.14 to 1.76, respectively). As in models for
the whole group, this suggests that effects of
the two pollutants were largely independent,
but in this case, the increased standard error
for the effect of03 was pardydue to aloss of
214 person-days ofsymptom observations in
LS asthmaticswhen co-regressingwithPM10.
In contrast, for MS asthmatics there
was little to no change in the parameter
estimates for current day 0 or PM10 sin-
gle pollutant versus co-pol?utant models,
and both 1-hr maximum PM10 (OR =
2.18) and 8-hr maximum PM1O (OR =
1.74) remained significant (p<0.0002 and
p<0.009, respectively). Co-pollutant mod-
els for 5-day moving averages of 1-hr, 8-hr,
and 24-hr PM10 (controlling for current
day 1-hr 03) were virtually unchanged
from models with PM1O alone. Odds ratios
for 03 in MS asthmatics were still small
and nonsignificant in co-pollutant models
controlling for current day 24-hrPM1O.
The models for MS asthmatics adjusted
for confounding day ofweek trends due to
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higher symptoms and PM10 on weekdays
than on weekends. There was no such tem-
poral confounding in LS asthmatics. There
was no confounding ofPM10 or 03 effects
by either maximum temperature or mini-
mum or average relative humidity. There
were no effects of wind speed using any
averaging time on symptoms in either LS
or MS asthmatics (all p-values >0.4). Also,
there was no significant interaction
between 0 and PM1o (p<o.4). MultipAicative interaction of follow-up
symptom dassification (LS or MS) with each
air pollutant variable was tested in regression
models induding all subjects. A steeper slope
in LS asthmatics was suggested for both 03
expressions (z scores around 1.50), current
day 24-hr PM1O (zscore 1.36), and both 5-
day 8-hr and 24-hr PM1O (z scores around
1.2). OtherPM10 expressions had zscores for
interaction terms <0.7.
The robustness of the above models was
retested accounting for fungal partides. For
an increase from the minimum to 90th per-
centile offungi (seeTable 2) among MS asth-
matics, the OR for the prior 24-hr average
fungi was 1.43 (CI, 1.07-1.90), and the OR
for the prior 12-hr daytime fungi was 1.34
(CI, 0.95-1.90), controlling for day-of-week
trends. Similar effect levels were found in LS
asthmatics for both the prior 24-hr average
fungi (OR = 1.35; CI, 0.89-2.03) and 12-hr
daytime fungi (OR = 1.35; CI, 0.96-1.89).
There was no evidence that outdoor fungi
confounded effects ofany ofthePMIO or 03
variables in either MS orLS asthmatics.
The lack ofa significant effect of03 in
MS asthmatics was reevaluated given the
influence of 4 MS asthmatics on 03 para-
meter estimates involving the whole cohort
of 24 subjects (discussed above). A model
with these 4 subjects showed large and
highly significant ORs for 1-hr 03 (5.31;
CI, 4.54-6.22) and 8-hr 03 (3.64; CI,
2.41-5.51), in contrast to models with the
other 6 MS asthmatics (ORs -0.8).
Associations with PMIO variables were also
stronger and significant in these 4 subjects.
We then examined symptom-pollutant
relationships in pediatric LS asthmatics who
were on regularly scheduled doses of anti-
inflammatory medications (seven subjects)
versus those who were not (seven subjects).
Five ofthe subjects taking anti-inflammato-
ry medications were on inhaled corticos-
teroids and two were on cromolyn. Table 6
shows the results ofseparate regression mod-
els for the two LS asthmatic groups. A dra-
matic difference emerged, suggesting effect
modification by anti-inflammatory medica-
tions for both PM and 03. Findings for sin-
gle pollutant models are as follows. Positive
associations are shown with current day 8-hr
and 24-hr PMIO in both groups, but ORs
Table 5. Odds ratios (ORs) or asthma symptomsa in pediatric asthmatics in relation to 90th percentile
increases in PM10 and 03 concentrations: dependence on asthma symptom frequencyb and pollutant
averaging times in theAlpine, California, Panel Study, 1 August-30 October 1995
ORs (Cl) per
increase to 90th percentile
concentration ofPM10 or 03
Air pollutant range (minimum Models adjusting for
Airpollutantvariable to 90th percentile)c Single pollutant modelsd co-pollutante
Less symptomatic asthmatics
Current dayPM10
1-hr max 47 1.38(0.76-2.50) 1.10(0.58-2.08)
8-hr max 36 2.18(0.99-4.79) 1.77 (0.85-3.71)
24-hr mean 25 2.47 (1.23-4.95)** 2.08(1.12-3.83)*
5-Day moving average PM10
1-hr max 47 2.70 (0.71-10.24) 2.40(0.68-8.53)
8-hr max 36 4.84(1.21-19.42)* 3.97 (1.09-14.54)*
24-hr mean 25 4.03(1.22-13.33)* 3.35 (1.06-10.51)*
Currentday 03
1-hr max 58 ppb 2.15 (1.04-4.44)* 1.76(0.66-4.73)
8-hr max 46 ppb 1.92(0.97-3.80) 1.51 (0.65-3.49)
More symptomatic asthmatics
Current dayPM10
1-hr max 47 2.24(1.46-3.46)# 2.18(1.46-3.27)#
8-hr max 36 1.82 (1.18-2.81)** 1.74(1.15-2.63 )**
24-hr mean 25 1.50(0.80-2.80) 1.40 (0.77-2.53)
5-Day moving average PM10
1-hr max 47 2.18 (1.01-4.72)* 2.20 (1.02-4.76)*
8-hr max 36 2.25(1.16-4.38)* 2.21 (1.16-4.18)*
24-hr mean 25 1.95 (1.12-3.43)* 1.87 (1.11-3.13)*
Current day
1-hr max 58 ppb 1.25(0.75-2.08) 1.16(0.71-1.88)
8-hr max 46 ppb 1.22(0.81-1.86) 1.16(0.73-1.83)
Abbreviations: Cl,95% confidence interval; max, maximum.
'The asthma symptom severity score was dichotomized to no symptoms or symptoms not bothersome versus symptoms bothersome or inter-
fering with daily activities.
bLess symptomatic asthmatics were defined as having <20% of days with asthma symptoms that were bothersome or interfered with daily
activities during follow-up (14 asthmatics, 1,052 person-days of 03 observations, 838 person-days of PM10 observations); more symptomatic
asthmatics were defined as having >20% ofdays with asthma symptomsthatwere bothersome orinterfered with daily activities (10asthmat-
ics, 707 person-days of 03 observations, 607 person-days ofPM10 observations).
Values shown are pg/m exceptwhere indicated.
dSingle pollutant models involve 71 days for PM10 and 91 days for 03 models; there was no confounding by weather, and models for more
symptomatic asthmatics adjustforday-of-weektrends.
eAll PM10 models adjust for current day 1-hr maximum 03; 03 models for less symptomatic asthmatics adjust for current day 24-hrPM1, 03
models for more symptomatic asthmatics adjust for current day 1-hr maximum PM10. All co-pollutant models are for 71 days with nonmissing
PM10 data;therefore, single pollutant 03models are notstrictly comparable.
*p<0.05;**p<0.01; p<0.001
and significance levels are greater in subjects
not on anti-inflammatory medications.
Effects ofcurrent day 1-hrPM1O are suggest-
ed only in subjects not on anti-inflammatory
medications and are smaller than effects of
longer PMIO averaging times. The only sig-
nificant lag PM1O effect in subjects on anti-
inflammatory medications was the 8-hr max-
imum 2 days before the symptom report
(OR 1.64; CI, 1.13-2.37). No combination
of lags was significant (see Table 6, 5-day
averages). Adverse effects of lagged PM1O
were more clearly suggested in subjects not
on anti-inflammatory medications, with 1-
day, 3-day, and 4 day lags showing positive
associations. The 5-day moving average of
PMIO had the largest parameter estimates,
which were significant for all averaging times.
Relative effects of the 5-day PMIO variables
were 8-hr >1-hr >24-hr. The 8-hr maximum
PM1O expression showed an unusually strong
association with asthma symptoms. There
was a significant (p<0.0005) 10-times
increase in risk of symptoms in asthmatics
not on anti-inflammatory medications at the
90th percentile of daily 8-hr PM1O (59
pg/M3). Also, the effects of current day 03
are entirely isolated to asthmatics not on the
anti-inflammatory medications (1-hr maxi-
mum 03 p<0.002), and effect magnitudes
are double that of regressions for all 14 LS
asthmatic children inTable 5 (ORs 4 vs. 2).
Theonlysuggested lagged 03 effectswere for
2-daylags in relation to symptoms insubjects
on anti-inflammatory medications (OR =
2.41; CI, 1.26-4.61). Co-regressing 2-day
lags of both 8-hr 0 and 8-hr PM1O (see
above OR) reduced effect estimates from sin-
gle pollutant models (OR = 1.87 and 1.40,
respectively; bothp<O.1).
In the co-pollutant models presented in
Table 6, subjects on anti-inflammatory med-
ications showed nearly the same effects of
current day 8-hr and 24-hr PM1O (control-
ling for current day 1-hr 03) and 03 did not
improve model fit over PM alone. However,
for subjects not on anti-inflammatory medica-
tions, ORs for current day PMIO were all
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Table 6. Odds ratios (ORs) for asthma symptomsa among pediatric asthmatics in relation to 90th percentile
increases in PM10 and 03 concentrations: effect modification by anti-inflammatory medication use in less
symptomatic subjectsb; Alpine, California Panel Study, 1 August-30 October 1995
ORs (C1)dper
increase to 90th percentile
concentration ofPM10 or 03
Asthmatics on Asthmatics not on
Air pollutant range (minimum anti-inflammatory anti-inflammatory
Air pollutant variable to 90th percentile)c medicationse medicationsf
Single pollutant models
Current day PM10
1-hr max 47 1.15(0.50-2.70) 1.97 (0.94-4.11)
8-hr max 36 2.08 (0.70-6.22) 3.04(1.05-8.83)*
24-hr mean 25 2.53(0.96-6.65) 2.82 (1.26-6.28)*
5-Day moving average PM10
1-hr max 47 1.51 (0.18-12.71) 5.94(1.63-21.52)**
8-hr max 36 2.96(0.32-27.05) 9.66(2.80-33.21)#
24-hr mean 25 3.50(0.50-24.53) 4.56(1.76-11.85)#
Current day 03
1-hr max 58 ppb 1.20(0.46-3.15) 4.14(1.71-10.00)#
8-hr max 46 ppb 1.11 (0.55-2.21) 3.59(1.37-9.40)**
Co-pollutant modelsg
Current day PM10
1-hr max 47 1.08(0.48-2.41) 1.44(0.60-3.47)
8-hr max 36 2.08(0.83-5.22) 2.18(0.78-6.09)
24-hr mean 25 2.55(1.11-5.89)* 2.00 (1.01-3.97)*
5-Day moving average PM10
1-hr max 47 1.44(0.19-10.78) 5.08(1.44-18.00)*
8-hr max 36 2.83(0.26-22.51) 6.67 (1.97-22.59)#
24-hr mean 25 3.42(0.54-21.60) 3.20(1.30-7.84)*
Current day 03
1-hr max 58 ppb 0.97 (0.30-3.15) 3.93 (0.77-20.06)
8-hr max 46 ppb 0.94(0.45-1.97) 3.00(0.59-15.16)
Cl, 95% confidence intervals.
"The asthma symptom severity score was dichotomized to no symptoms or symptoms not bothersome versus symptoms bothersome or inter-
fering with daily activities.
bLess symptomatic asthmatics were defined as having <20% of days with asthma symptoms that were bothersome or interfered with daily
activities during follow-up.
cValues shows are pg/m3 except where indicated.
dSingle pollutant models involve 71 days for PM10 and 91 days for 03 models. Co-pollutant models are for 71 days with nonmissing PM1O data;
therefore, single pollutant 03 models are not strictly comparable. There was no confounding by weather or day-of-week trends.
"This includes seven subjects, five on inhaled corticosteroids and two on cromolyn, with 533 person-days of 03 observations and 424 person-
days ofPM10 observations.
'This includes seven subjects with 519 person-days of 03 observations and 414 person-days of PM10 observations.
CAll PM15 models adjustfor current day 1-hr maximum 03; all 03 models adjustfor current day 24-hr PM10.
*p<0.05;**p<O.Ol;#p0.001.
reduced by27-29% and standard errors (SEs)
are inflated (only 24-hr PMIO is still signifi-
cant). There is a similar finding for the 5-day
average PM1O variables, but they remain sig-
nificant. Also, for subjects not on anti-inflam-
matory medications, current day 03 is not sig-
nificant in co-pollutant models (controlling
for current day 24-hr PM10), but the ORs are
similar to single pollutant 03 models. Again,
the regression with 03 alone was rerun,
restricted to the 71 days. One-hour 03
showed a somewhat higher OR (4.65) than
the co-pollutant model (3.93), although itwas
also not signfficant (p<0.07). A similar differ-
ence was found for the effect of 8-hr 03 in a
71-daymodel (OR = 3.68;p<O.1 1) compared
with theco-pollutant model (OR = 3.00). The
restriction to fewer days, therefore, partly
explains a lack ofstatistical significance in the
co-regression. The effect of current day 1-hr
03 was also retested by co-regressing with the
5-day average of 8-hr PM1O and the OR for
03 increased (4.24;p<o.1).
There was no confounding ofPM1O or
03 effects bydayofweek, maximum temper-
ature, or minimum or average relative
humidity for either ofthe two groups (on or
not on anti-inflammatory medications).
There were no effects ofwind speed using
any averaging time on symptoms in either
group (allp-values >0.4). An interaction term
for 03 and PM1O did not improve the fit of
the above models (deviance difference <2.0).
Again, the robustness ofthe above mod-
els in the two groups was retested account-
ing for fungal particles. For LS asthmatic
children taking anti-inflammatory medica-
tion, there was no effect offungi (p>0.6). In
contrast, there were significant effects of
fungi on asthmatic children not taking anti-
inflammatory medication. For an increase
from the minimum to 90th percentile of
fungi (see Table 2), the OR for the prior
24-hr average fungi was 1.70 (CI,
1.03-2.78), and the OR for the prior 12-hr
daytime fungi was 1.61 (CI, 1.05-2.46).
Fungal particles did not confound effects of
anyPMIO or 03 variable, and the significant
pollutantvariables remained significant.
Multiplicative interaction between the
use of anti-inflammatory medications and
each air pollutant variable was tested in
regression models including all LS subjects.
A steeper slope in asthmatics not taking
anti-inflammatory medications was sug-
gested for both 03 expressions (z scores
around 1.80) and fungal spores (z score
1.60). Slopes were also steeper in asthmat-
ics not taking anti-inflammatory medica-
tions for PMIO variables, but z scores were
only around 1.0.
Cromolyn and nedocromil have differ-
ent mechanisms ofaction and are less potent
and effective anti-inflammatory medications
than inhaled corticosteroids (8). Therefore,
models were retested dropping the two LS
asthmatics on these medications and retain-
ing five subjects on inhaled corticosteroids.
The only change was a decrease in the effect
ofcurrent day 24-hr PM1O and a loss ofsig-
nificance (OR = 2.12; CI, 0.53-8.44).
Remaining models showed no pollutant
association as in models including the seven
on anyanti-inflammatory medication.
To test the linearity of associations for
all of the above analyses, higher pollutant
days were dropped and models were retest-
ed. For 03, 5 days with over 120 ppb 1-hr
maximum (the previous NAAQS) and the
same 5 days with over 100 ppb 8-hr maxi-
mum were dropped and models were retest-
ed. This was repeated dropping the highest
10% ofdays (110 ppb 1-hr maximum and
90 ppb 8-hr maximum) and dropping the
25 days over the new 8-hr standard of 80
ppb 03. Associations disappeared below the
120 ppb threshold in the models induding
the whole group and in MS asthmatic mod-
els (p>0.4), but 03 was still associated with
symptoms below 120 ppb in the four sensi-
tive MS asthmatics (ORs = 2.57-3.77), but
not below 100 ppb. Effects were also found
at lower 03 levels for LS asthmatics, with
effect magnitudes that were relatively
unchanged (days <110 ppb maximum 03,
OR = 2.54; CI, 0.93-6.94). Although drop-
ping 25 days with over 80 ppb 8-hr maxi-
mum led to a nonsignificant parameter esti-
mate (p<0.14), the slope was still positive
(OR = 4.20). Lower concentration effects
were also evident in LS asthmatics not on
anti-inflammatory medications, including
the model excluding days with over 80 ppb
8-hr maximum 03 (p<0.005). This suggests
a linear dose-response relationship for 03
and symptoms in the most sensitive sub-
jects, but a possible threshold in other sub-
jects. For the PM1O variables, the highest
10% ofdays was dropped and models were
retested. For all models, parameter estimates
Volume 106, Number 1 1, November 1998 * Environmental Health Perspectives 758Articles * Asthma symptoms and air pollution
were either unchanged or actually increased,
and they often remained statistically signifi-
cant if so for above models including all
observed days. For example, in the model
that included all asthmatics, dropping 10%
ofdays above 77 pg/m3 for current day 1-hr
maximum PMIO led to an OR of 1.89 (CI
1.20-2.98). The effects ofthe 5-day moving
average for 8-hr maximum PM1O below 53
pg/m in LS asthmatics not on anti-inflam-
matorymedication was reduced to an ORof
2.77 (p<O.l14). Overall, however, these
results suggest a linear dose-response rela-
tionship forPMIO and symptoms.
Discussion
Overview ofFindings
The present findings are consistent with
other recent asthma panel studies conducted
with diverse populations of children that
found adverse effects on daily asthma severi-
ty byPM0o and 03 in warm periods and by
PMIO in winter (20-26). Panel studies
focusing on adult asthmatics have also
found adverse effects of air pollution on
daily asthma severity (27-29). Multiday
moving averages ofPM1O had greater effects
than single day expressions in the studies
examining such variables, which is consis-
tent with the present findings. The present
study adds to previous findings because it is
the first to report particle effects from 1-hr
and 8-hr maximum PM10 as compared with
the standard metric of24-hr means. We also
show informative differences in the strength
of symptom-pollutant associations between
groups ofasthmatics stratified on their level
ofdaily asthma symptom frequency and on
anti-inflammatory medication use. Outdoor
fungal particles were alsosignificantly associ-
ated with asthma symptoms, but did not
confound effects of either PMIO or 03,
which is consistent with our previous studies
(15,18). Our findings are summarized
below. In most cases, the ordering ofrelative
magnitudes of association for the various
pollutant variables is imprecise because their
confidence intervals overlap markedly (see
tables). We present the ordering as a point
ofdiscussion to generate hypotheses and to
prompt others to replicate or refute the rela-
tivestrengths ofassociation.
* In the whole group of 24 pediatric asth-
matics, relative effect magnitudes across
the different pollutants and averaging
times for current day measurements were
1-hr PM10_ 8-hr PM1O >1-hr 03 _ 8-hr
O3 _ 24-hrPM1O, with the tightest confi-
dence intervals and most robust associa-
tions in co-pollutant models being for 1-
hr and 8-hr maximumPM1O (Table 4).
*There were notable differences in pollutant
effects between 14 less versus 10 more
symptomatic asthmatics (Table 5): 1) asso-
ciations with current day 0 were found
only in LS asthmatics, but four MS asth-
matics showed strong 03 effects in contrast
to the remaining six; 2) relative effect mag-
nitudes across PM10 averaging times for
current day measurements were inversely
ordered for LS versus MS asthmatics (LS
asthmatics: 24-hr >8-hr >1-hr PM10; MS
asthmatics: 1-hr >8-hr > 24-hrPM10); and
3) relative effect magnitudes across PM1O
averaging times for 5-day moving averages
were also different, with largereffects for all
averaging times in LS asthmatics (LS asth-
matics: 8-hr >24-hr >1-hr PM1O; MS asth-
matics: 1-hr_ 8-hr >24-hrPM10).
*Among the LS asthmatics, there was evi-
dence of effect modification by anti-
inflammatory medication use (Table 6): 1)
associations with current day 03 were
found only in those not on anti-inflamma-
tory medications, and effect sizes were
nearly three times those found in the mod-
els involving all subjects (OR -4.0 versus
1.5); 2) relative effect magnitudes for cur-
rentdayPM0oweresimilarbetween groups
on or off medication, reflecting results for
the combined LS group (8-hr _24hr >1-hr
PM10); but, there were no PM1O effects in
subjects on corticosteroids; 3) there were
no 5-day PM10 effects in subjects on anti-
inflammatory medications, but significant
and large effects were found in those not
medicated (for 5-day PM1O, 8-hr >1-hr
>24-hr PM1O; 90th percentile ORs were
6.67, 5.08, and 3.02, respectively, adjusted
for 03); and4) amongLS asthmatics, there
was no effect ofoutdoor fungi in subjects
taking anti-inflammatory medication,
whereas in unmedicated subjects the signif-
icantlyadverse effect offungiwas enhanced
in comparison to the whole panel (24-hr
average fungi, ORs 1.70 versus 1.36,
respectively).
Effects ofParidcles
To our knowledge, this is the first paper to
show the potential importance ofpeak (1-
hr and 8-hr) PM10 exposures to adverse
respiratory effects of particles in an epi-
demiologic study. There are no published
experimental studies to our knowledge that
have directly examined the issue of differ-
ences in particle effects by concentration x
time exposure profile for a single adminis-
tered dose. In general, we found larger
associations with asthma symptoms for 1-
hr and 8-hr maximum PM1O exposures, as
compared with the standard metric of 24-
hr average PM10. This was found with
effects ofcurrent day PM1O in the subpop-
ulation of MS asthmatics (Table 5) and
with effects of 5-day PM10 in LS asthmat-
ics not on anti-inflammatory medications
(Table 6). Among the seven LS asthmatics
not on anti-inflammatory medications, the
5-day moving average of 8-hr maximum
PM10 was associated with a 10 times higher
risk of adverse asthma symptoms (seven
times higher adjusted for 03) at the 90th
percentile of8-hrPM1O (59 pug/m3) relative
to the minimum pollution day (23 pg/m3;
p<0.0005) (Table 6). This suggests that
there may be a subgroup ofasthmatics who
potentially are very susceptible to daytime
excursions ofparticulate airpollution.
The mechanism of particle effects in
some of the LS asthmatics may have been
more dependent on cumulative exposures
(as represented by 5-day moving averages),
leading to more gradual inflammatory
responses. In contrast, effects in some of
the MS asthmatics could have been mediat-
ed more by short-term (current day) peak
exposures, leading to more immediate
bronchoconstrictive and inflammatory
responses similar to aeroallergen effects
involving immediate and late phase bron-
chospastic reactions (4-6 hr later) induced
by an initial IgE-mediated response (30).
Differences in medication use in the two
groups, particularly anti-inflammatory
medications, may have also modified
responses to air pollutants. Another possi-
bility is that differences between averaging
times could be due to interindividual dif-
ferences in the relevance of outdoor sta-
tionary site PM10 to personal particle expo-
sures. Given that the strongest effects were
for 8-hr exposures over the current and
previous 4 days, it is possible that maximal
personal exposures occurred around the
same 8-hr time period from late morning
to early evening. This is a time when many
children are outdoors and physically active.
Other investigators have similarly
explained stronger effects from 5-day mov-
ing averages. In a study of a nonstratified
group of asthmatic children living in
Amsterdam (24), adverse effects on lower
respiratory symptoms were also found for
similarly low 5-day mean concentrations of
24-hr PM1O (symptom prevalence differ-
ence between the highest day, 60 pg/mi3,
vs. the lowest day, 16 pg/m3, relative to the
mean prevalence was 1.47; CI, 1.00-1.94).
Smaller effects for current day 24-hr PM1O
were found (1.23; CI, 0.92-1.54). This led
authors to hypothesize that cumulative
(long-term averaged) exposure variables are
less affected by exposure misclassification
due to temporally variable differences in
personal exposures because variation in
exposure estimates are averaged out.
We did not expect that asthma symp-
toms would be strongly associated with the
low levels ofpartides in Alpine, California
(all observations <109 pg/m3 for hourly
Environmental Health Perspectives * Volume 106, Number 1 1, November 1998 759Articles * Delfino et al.
PM1O). In regression models involving sub-
populations of children incorporating both
PMIO and 03, the effects ofPM1O variables
were usually still statistically significant and
only reduced in magnitude in LS asthmatic
children. These findings suggest that the
irritant potential ofPM1O at inversion layer
elevations may be considerably greater than
expected based upon mass. This supports
the view that considerable scientific work is
required to determine the causal compo-
nents of particles, components that may
have adverse effects at low mass concentra-
tions (e.g., the ultrafine particle fraction,
polycyclic organic compounds, metals,
etc.). The relevant particle toxicities (in this
region at least) appear to be largely inde-
pendent of 03, suggesting an important
role in partide effects by primary combus-
tion products, which in Southern California
are primarilyfrom automobile exhaust.
Effects ofOzone
The findings of the present study support
the view that asthmatics may be a group
particularly sensitive to the adverse respira-
tory effects of trophospheric 03 (31).
Recentevidence suggests that a major mech-
anism for this may be the effect of 03 on
airway inflammation (6), in addition to less
notable effects on acute lung function
responses, possibly neurally mediated (32).
This evidence was found in an experimental
chamber study of 18 asthmatic and 81 nor-
mal adult subjects exposed to 197 ppb 03
over 4 hr, with 50 min/hr oftreadmill exer-
cise (6). There were no differences between
the groups in the significant 03-induced
deficits in forced expiratory volume in 1 sec
(FEV1) or in forced vital capacity (FVC).
However, a nonsignificant trend of
increased specific airway resistance (sRaw)
was noted in asthmatics versus normal sub-
jects. Also, two inflammatory markers (per-
centage of neutrophils and total protein
concentration) in BAL fluid were signifi-
cantly increased in asthmatics 18 hr follow-
ing 03 exposure as compared with 20 nor-
mal subjects undergoing BAL. These
changes were not correlated with decre-
ments in FEV1 or FVC, but were signifi-
cantly correlated with sRaw. Scannell et al.
(6) concluded that 03-induced changes in
sRaw could reflect airway inflammation,
possibly mediated through a decrease in air-
way caliber from mucosal edema. These
findings are supported by other experimen-
tal studies in humans showing evidence of
03-induced inflammation in BAL fluid
(33-36). Our epidemiologic findings are
consistent with these experimental results
because of the near tripling of 03 response
magnitude among LS asthmatic children
not taking anti-inflammatory medications,
compared with the whole group, and the
lackofresponse in medicated LS asthmatics.
The finding that subjects on anti-
inflammatory medications showed no
effect of 0 is countered somewhat by
another epidemiologic study (37). In that
recent study of 166 asthmatic children
attending one of three week-long asthma
summer camps, 71% regularly used
inhaled anti-inflammatory medications.
There was a significantly increased risk of
an asthma exacerbation (RR = 1.4) and of
experiencing chest symptoms (RR = 1.4)
on the highest pollution day (03, 160 ppb)
versus the average day (03, 84 ppb).
Higher 03 levels were found in that study,
with the previous NAAQS of 120 ppb 1-hr
03 being exceeded on 25% of the study
days, versus only 5% in the present study.
The effects of03 in the LS but not MS
asthmatic group are informative. The relative
lack of03 effects in models induding all 10
pediatric MS asthmatics is unexpected
because onlyone ofthese subjects was taking
an anti-inflammatory medication. However,
when a modelwas tested induding the 4 MS
asthmatics found to influence 03 parameters
in the whole group analysis, significant and
strong associations were found for 03 (1-hr
03, OR = 5.31; p<O.00005). It is possible
that for the MS asthmatics not showing an
03 effect, their greater symptom severity
during follow-up as compared with the LS
asthmatics was due to other exposures unre-
lated to 03. For example, indoor allergens
may have driven their day-to-day symptom
variability. It is also possible that these MS
asthmatics may have avoided being outdoors
and/or avoided outdoor physical activity,
with an attendant lowering of potential
delivered 03 dose given the low indoor/out-
door 0 ratio (around 0.3) (38) and
decreasedminuteventilation.
Relevance to EPAAir Pollution
Standards
TheAlpinegovernmental monitoring station
is part ofthe nationwide EPA network. On
only 2 of the days monitored (every sixth
day) between 1981 to 1985 didlevels oftotal
suspended particulates (induding 10-50 pm
particles) exceed the old federal standard of
260 pg/m3, after which governmental moni-
toringforparticulates was discontinued. This
is in contrast to 03 levels, which are histori-
cally the highest in San Diego County. We
originally had little expectation of particle
effects. In our previous report on 22 asth-
matics followed in Alpine during the spring
of 1994, we found no association between
ordinal asthma symptoms and either 03 or
24-hr average TEOM PM1O, despite similar
pollutant levels (15). There were modest
associations between as-needed ,B-agonist
inhaler use (a surrogate ofsymptom severity)
and 24-hr PM1O. Some critical irritant char-
acteristics ofthe particles could have differed
between then and the fall 1995 period. More
importantly, there was no stratification of
subjects similar to the present report and no
analysis ofbinarysymptom scores. Areanaly-
sis ofthatdatais planned.
The EPA's previous NAAQS for particu-
late air pollution was set at a 24-hr average
PMIO concentration of150pg/m3. The EPA
has recendy revised the NAAQS for particu-
late air pollution that centers on adding a
new primary PM25 standard of 50 pg/m3
24-hr daily average concentration. The new
PM2.5 standards make it likely that more
U.S. regions will exceed that NAAQS, but
the EPA is retaining the previousPMIO stan-
dard with less stringent attainment criteria.
Because the maximum day's 24-hrPM1Owas
only 42 pg/m3, it is extremely unlikely that
the new PM25 standard was ever exceeded
during the study period. This means that
partide effects may be determined by factors
not entirely dependent on mass and/or that
setting standards based on 24-hr averages
will miss important short-term excursions
during peak exposure periods. This could
further explain the lack ofparticle effects on
symptoms in the 1994 study (15) becausewe
did notexaminepeakPM1O.
The EPA is also tightening the NAAQS
for 03 to an 80 ppb 8-hr maximum daily
concentration from the previous 120 ppb
1-hr standard. Therefore, it is of current
relevance that in this study the 1-hr maxi-
mum 03 showed slightly stronger effects
than the 8-hr averaging time. Findings may
differ when accounting for outdoor activity
profiles because the maximal exposure in
the afternoon is also the time of highest
hourly 03 levels. Although the 8-hr average
was slightlyless informative in this analysis,
the effects found suggest that the new
NAAQS would probably afford better pro-
tection ofthe susceptible asthmatic popula-
tion than the current one. The reason is
that the previous NAAQS of 120 ppb 1-hr
maximum 03 was only exceeded 5 times,
whereas the new NAAQS of 80 ppb 8-hr
maximum 03 was exceeded 25 times.
Implications for Future Research
A key strength of the present findings is that
the measure ofasthma symptom severity we
use accounts for some aspects ofdaily well-
being as assessed by the individual. Additional
researchshould incorporatesimilarapproaches
to asthma outcome assessment. The present
finding ofmajor differences in air pollution
effects between asthmatics with less versus
more frequent asthma symptom episodes dur-
ing follow-up is directly dependent on the
symptom scoring approach. The dassification
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is also based on daily longitudinal data, which
is expected to yield a more accurate descrip-
tion of an individual's asthma severity than
historical questionnaire data.
The design ofthe present study made it
possible to find informative differences in air
pollutant effects on small subgroups ofasth-
matic children. As discussed above, the
repeated measures design can yield powerful
analyses with large sample sizes (person-days)
forsmall numbers ofsubjects. The limitation
with smaller numbers ofsubjects is that it is
more difficult to generalize results to asth-
matics as a group or to asthmatics with the
characteristics ofthe subpopulations present-
ed herein. To this end, larger panel studies
are needed in diverse populations to examine
the types ofhost susceptibility suggested by
the present subgroup analyses. Additional
workis also needed to quantifyasthmasever-
ity according to symptom reports (e.g.,
repeated spirometry). For instance, some
asthmatics appear to be poor perceivers of
bronchoconstriction, particularly those with
chronic airflow obstruction (39), while oth-
ers mayover-report symptom severity.
The results presented support the
hypothesis that current day hourly peak
PM1O, as well as multiple-day cumulative
average exposures using 8-hr PM10 maxi-
mums, may be more informative in explain-
ing observations ofadverse partide effects on
acute asthma severity than current or multi-
ple-day 24-hr average PM10 exposures. It is
possible, for instance, that outdoor peaks in
PMIO are better surrogates for personal out-
doorexposures during the daytime, exposures
that can often occur at times ofhigh physical
activity leading to greater particle doses.
Confirmation of this will require research
incorporating real time PM sampling and
personal particle exposure assessments. In
addition, relative effects ofPM1O and 03 may
differ in subgroups ofasthmatics depending
on their current disease severity. Forexample,
it is expected from experimental data that
particle deposition and retention is greater in
the airways ofmore severe as compared with
milder asthmatics (40). As evidenced in this
paper, acute responses to the delivered dose
are likely to be further modified by anti-
inflammatory medication use. Additional evi-
dence for the biological plausibility and con-
sistency of the associations presented here is
expected to advance understanding of the
determinants of susceptibility to adverse
effects ofair pollutants, induding short-dura-
tion exposure to highparticle excursions.
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